4//SEC Filing
ACHILLION PHARMACEUTICALS INC 4
Accession 0001209191-15-087386
CIK 0001070336operating
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:25 PM ET
Size
9.1 KB
Accession
0001209191-15-087386
Insider Transaction Report
Form 4
Fenton Mary Kay
Vice President and CFO
Transactions
- Exercise/Conversion
Common Stock
2015-12-28$1.05/sh+43,500$45,675→ 43,500 total - Exercise/Conversion
Employee Stock Option
2015-12-28−43,500→ 0 totalExercise: $1.05Exp: 2018-12-15→ Common Stock (43,500 underlying) - Sale
Common Stock
2015-12-28$10.08/sh−43,500$438,480→ 0 total
Footnotes (2)
- [F1]The price in column 4 is a weighted average price. The actual sale prices for these transactions ranged from $9.97 to $10.21. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]This option was granted on December 15, 2008 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three month-month period thereafter.
Documents
Issuer
ACHILLION PHARMACEUTICALS INC
CIK 0001070336
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070336
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:25 PM ET
- Size
- 9.1 KB